Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Taysha Gene Therapies (TSHA) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for Taysha Gene Therapies (TSHA) over the last 4 years, with Q3 2025 value amounting to 0.02.

  • Taysha Gene Therapies' Asset Utilization Ratio fell 6272.82% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 6272.82%. This contributed to the annual value of 0.05 for FY2024, which is 5158.74% down from last year.
  • Latest data reveals that Taysha Gene Therapies reported Asset Utilization Ratio of 0.02 as of Q3 2025, which was down 6272.82% from 0.03 recorded in Q2 2025.
  • In the past 5 years, Taysha Gene Therapies' Asset Utilization Ratio ranged from a high of 0.09 in Q1 2024 and a low of 0.03 during Q4 2022
  • Its 4-year average for Asset Utilization Ratio is 0.05, with a median of 0.05 in 2023.
  • As far as peak fluctuations go, Taysha Gene Therapies' Asset Utilization Ratio soared by 52679.32% in 2024, and later plummeted by 6272.82% in 2025.
  • Over the past 4 years, Taysha Gene Therapies' Asset Utilization Ratio (Quarter) stood at 0.03 in 2022, then skyrocketed by 362.47% to 0.08 in 2023, then crashed by 41.65% to 0.05 in 2024, then crashed by 60.32% to 0.02 in 2025.
  • Its last three reported values are 0.02 in Q3 2025, 0.03 for Q2 2025, and 0.05 during Q1 2025.